Acute cardiac injury is associated with adverse outcomes, including mortality in COVID-19 patients

References

1. ↵
   1. Zhu N,
   2. Zhang D,
   3. Wang W,
   4. Li X,
   5. Yang B,
   6. Song J,
   7. et al.

   (2020) A Novel coronavirus from patients with pneumonia in China 2019. N Engl J Med 382:727–733.

   OpenUrlCrossRefPubMed
2. ↵
   1. Johns Hopkins Coronavirus Resource Center

   Center for Systems Science and Engineering (CSSE) at Johns Hopkins University U, cited 2020, Available from: https://coronavirus.jhu.edu/map.html.
3. ↵
   1. Huang C,
   2. Wang Y,
   3. Li X,
   4. Ren L,
   5. Zhao J,
   6. Hu Y,
   7. et al.

   (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506.

   OpenUrlCrossRefPubMed
4. ↵
   1. Wang D,
   2. Hu B,
   3. Hu C,
   4. Zhu F,
   5. Liu X,
   6. Zhang J,
   7. et al.

   (2020) Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061–1069.

   OpenUrlCrossRefPubMed
5. ↵
   1. Shi S,
   2. Qin M,
   3. Shen B,
   4. Cai Y,
   5. Liu T,
   6. Yang F,
   7. et al.

   (2020) Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology, e200950.
6. ↵
   1. Chen C,
   2. Zhou Y,
   3. Wang DW

   (2020) SARS-CoV-2:a potential novel etiology of fulminant myocarditis. Herz 45:230–232.

   OpenUrlPubMed
7. ↵
   1. Zheng YY,
   2. Ma YT,
   3. Zhang JY,
   4. Xie X

   (2020) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17:259–260.

   OpenUrlCrossRefPubMed
8. ↵
   1. B K A,
   2. Chaudhuri D

   (2020) A review of acute myocardial injury in coronavirus disease 2019. Cureus 12:e8426.

   OpenUrl
9. ↵
   1. Singer M,
   2. Deutschman CS,
   3. Seymour CW,
   4. Shankar-Hari M,
   5. Annane D,
   6. Bauer M,
   7. et al.

   (2016) The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810.

   OpenUrlCrossRefPubMed
10. ↵
    1. Force TADT

    (2012) Acute Respiratory Distress Syndrome:The Berlin Definition. JAMA 307:2526–2533.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Khwaja A

    (2012) KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clinical Practice 120:c179–c184.

    OpenUrlCrossRefPubMed
12. ↵
    (2020) Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41:145–151, Chinese.

    OpenUrlCrossRefPubMed
13. ↵
    1. Wu C,
    2. Chen X,
    3. Cai Y,
    4. Xia Ja,
    5. Zhou X,
    6. Xu S,
    7. et al.

    (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine 180:934–943.

    OpenUrl
14. ↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z,
    7. et al.

    (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China:a retrospective cohort study. The Lancet 395:1054–1062.

    OpenUrlCrossRef
15. ↵
    1. Shi S,
    2. Qin M,
    3. Shen B,
    4. Cai Y,
    5. Liu T,
    6. Yang F,
    7. et al.

    (2020) Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology 5:802–810.

    OpenUrl
16. ↵
    1. Zeng JH,
    2. Liu YX,
    3. Yuan J,
    4. Wang FX,
    5. Wu WB,
    6. Li JX,
    7. et al.

    (2020) First case of COVID-19 complicated with fulminant myocarditis:a case report and insights. Infection 48:773–777.

    OpenUrlPubMed
17. ↵
    1. Hu H,
    2. Ma F,
    3. Wei X,
    4. Fang Y

    (2020) Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. European Heart Journal 16:ehaa190.

    OpenUrl
18. ↵
    1. Caforio ALP,
    2. Pankuweit S,
    3. Arbustini E,
    4. Basso C,
    5. Gimeno-Blanes J,
    6. Felix SB,
    7. et al.

    (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis:a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal 34:2636–2648.

    OpenUrlCrossRefPubMedWeb of Science